Pulmonx Corp (LUNG) - 8-K Summary
Business Context and Reporting Period
This Form 8-K, dated October 21, 2025, reports significant executive leadership transitions and references preliminary financial results for the third fiscal quarter ended September 30, 2025. The filing details the resignation of the CEO and CFO and the appointment of new leadership effective late October and early November 2025.
Key Financial Metrics
The filing references a press release regarding Q3 2025 revenue but does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity within this document. Specific financial figures are contained in the attached Exhibit 99.1 (Press Release) and are not explicitly stated in the text of this 8-K.
Material Changes: Executive Leadership
The company underwent a complete overhaul of its C-suite leadership:
- CEO Resignation: Steven S. Williamson resigned as President, CEO, and Board member, effective October 27, 2025.
- CFO Resignation: Mehul Joshi resigned as CFO, effective October 27, 2025.
- New CEO: Glendon E. French was appointed President and CEO, effective October 27, 2025. Mr. French previously served as CEO from 2014 to 2024.
- New CFO/COO: Derrick Sung, Ph.D., was appointed Chief Operating Officer and CFO, effective November 3, 2025. Dr. Sung previously served as the company's CFO from 2019 to 2023.
Compensation, Guidance, and Risks
Separation Agreements:
- Steven S. Williamson: Receives $600,000 over 12 months plus COBRA reimbursement (14 months). A consulting fee of $50,000 is payable through December 1, 2025.
- Mehul Joshi: Receives $347,625 over 9 months plus COBRA reimbursement (11 months). A consulting fee of $30,000 is payable through December 1, 2025.
New Executive Compensation:
- Glendon E. French: Base salary of $625,000 with a 100% target bonus. Granted 1.2 million RSUs and 800,000 PSUs. PSU vesting is contingent on the stock price averaging over $4.00 for 60 consecutive trading days.
- Derrick Sung: Base salary of $500,000 with a 60% target bonus. Granted 1.2 million RSUs and 400,000 PSUs. PSU vesting is contingent on the stock price averaging over $4.00 for 60 consecutive trading days.
Outlook and Risks: The filing indicates a focus on an "orderly leadership transition." The performance conditions for new equity awards (stock price > $4.00) suggest management targets a specific valuation threshold. No specific forward-looking revenue guidance is provided in this text.
Investor Verification Checklist
- Review the attached Press Release (Exhibit 99.1) for specific Q3 2025 revenue figures and full financial results.
- Verify the current stock price relative to the $4.00 performance threshold required for new executive PSU vesting.
- Monitor the transition period through December 1, 2025, when the outgoing executives' consulting agreements expire.
- Assess the impact of the leadership changes on the company's strategic direction and operational stability.